These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 3628222)
1. Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats. Otsuki M; Ohki A; Okabayashi Y; Suehiro I; Baba S Pancreas; 1987; 2(2):164-9. PubMed ID: 3628222 [TBL] [Abstract][Full Text] [Related]
2. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion. Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W Digestion; 1984; 30(3):171-8. PubMed ID: 6209186 [TBL] [Abstract][Full Text] [Related]
3. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats. Göke B; Fenchel K; Knobloch S; Arnold R; Adler G Pancreas; 1988; 3(5):576-9. PubMed ID: 3186685 [TBL] [Abstract][Full Text] [Related]
4. Intracellular mechanism responsible for reduced enzyme secretion from camostate-induced hypertrophied pancreas. Herzig KH; May D; Louie DS; Takahashi T; Göke B; Owyang C Digestion; 1990; 46 Suppl 2():195-201. PubMed ID: 1702070 [TBL] [Abstract][Full Text] [Related]
5. Age-dependent influence of octreotide on stimulated pancreatic growth in the postnatal period of rats. Kisfalvi K; Friess H; Büchler MW; Tulassay Z; Varga G; Papp M Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):69-74. PubMed ID: 8900912 [TBL] [Abstract][Full Text] [Related]
6. Endocrine and exocrine pancreatic function after camostate-induced growth of the organ. von Schönfeld J; Rünzi M; Goebell H; Müller MK Experientia; 1995 Jun; 51(6):556-60. PubMed ID: 7607295 [TBL] [Abstract][Full Text] [Related]
7. Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate). Göke B; Printz H; Koop I; Rausch U; Richter G; Arnold R; Adler G Pancreas; 1986; 1(6):509-15. PubMed ID: 3562444 [TBL] [Abstract][Full Text] [Related]
8. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats. Miyasaka K; Nakamura R; Kitani K J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305). Lhoste EF; Roebuck BD; Longnecker DS Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478 [TBL] [Abstract][Full Text] [Related]
10. Effect of atropine on feedback regulation of pancreatic secretion in rats. Weidenbach H; Printz H; Göke B; Koop I; Schafmayer A; Adler G Res Exp Med (Berl); 1989; 189(3):221-8. PubMed ID: 2473503 [TBL] [Abstract][Full Text] [Related]
11. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas. Wisner JR; McLaughlin RE; Rich KA; Ozawa S; Renner IG Gastroenterology; 1988 Jan; 94(1):109-13. PubMed ID: 3335282 [TBL] [Abstract][Full Text] [Related]
12. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini. Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829 [TBL] [Abstract][Full Text] [Related]
13. Effect of a specific serine protease inhibitor on the rat pancreas. II. Influence of camostate on the endocrine pancreas. Göke B; Siegel EG; Stöckmann F; Lankisch PG; Creutzfeldt W Digestion; 1985; 31(2-3):128-35. PubMed ID: 3888752 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Niederau C; Liddle RA; Williams JA; Grendell JH Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964 [TBL] [Abstract][Full Text] [Related]
15. Chronic effects of camostate on growth and endocrine function of the pancreas in streptozotocin-induced diabetic rats. Kogire M; Inoue K; Gu Y; Uchida K; Imamura M Proc Soc Exp Biol Med; 1993 Nov; 204(2):201-5. PubMed ID: 8415777 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of pancreatic secretion in man by a protease inhibitor (camostate). Adler G; Müllenhoff A; Koop I; Bozkurt T; Göke B; Beglinger C; Arnold R Eur J Clin Invest; 1988 Feb; 18(1):98-104. PubMed ID: 3130267 [TBL] [Abstract][Full Text] [Related]
17. Subcutaneous administration of the synthetic trypsin inhibitor Foy-305 induces hypertrophy of the exocrine pancreas. Wereszczyńska-Siemiatkowska U; Pohl U; Otto J; Lankisch PG Digestion; 1987; 37(3):144-8. PubMed ID: 2443410 [TBL] [Abstract][Full Text] [Related]
18. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat. Varga G; Kisfalvi K; D'Amato M; Scarpignato C J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the effect of single and repeated administrations of a protease inhibitor (Camostate) on pancreatic secretion in man. Adler G; Müllenhoff A; Bozkurt T; Göke B; Koop I; Arnold R Scand J Gastroenterol; 1988 Mar; 23(2):158-62. PubMed ID: 3363288 [TBL] [Abstract][Full Text] [Related]
20. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy. Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W Digestion; 1989; 44(2):105-16. PubMed ID: 2612749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]